PMID 33831374
When it comes to Mysimba, it's currently not available in Germany
Interpretation Subcutaneous semaglutide had significant benefits on weight loss with reasonable safety in overweight or obese adults
Nonetheless, individualised risk assessment remains essential, particularly in patients with complex medical backgrounds
A meta-analysis of 77 RCTs involving 50,820 patients with T2DM found that compared with placebo, lifestyle modification, or active anti-diabetic drugs, SGLT2is were associated with a significantly higher risk of genital infections (RR, 3.30
November 13, 2025: 1 in 8 Americans Have Tried Ozempic and Other GLP-1s According to recent survey data, about 12% of Americans have been prescribed Ozempic or a similar GLP-1 drug